Indo Euro Indch. (524458)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/B of 1.01 means the market price is nearly equal to book value of ₹14.88 per share, offering a perceived asset backstop.
• ROCE of 7.05% is positive, indicating some capital productivity even at a depressed scale.
• With a market cap of only ₹14 crore, even a small absolute improvement in sales and profits could move the stock meaningfully.

Concerns

• Revenue and profit collapsed by 70.21% and 95.24% respectively; latest quarter net profit is essentially zero.
• P/E of 72.12 is distorted and unattractive on currently depressed earnings, while ROE of only 1.59% provides negligible return.
• Piotroski F-score of 3/9 suggests weak financial health and possible operating stress.
• No dividend and no promoter holding data reduce shareholder comfort and transparency.

AI Analysis

Let me be blunt: Indo Euro Indch is exactly the kind of small specialty chemical name I would circle cautiously and then most likely walk past. With a market cap of just ₹14 crore and latest quarter sales of ₹1 crore, this is a micro-cap in every sense. The sticker price looks cheap on a P/B of 1.01, but cheapness is only meaningful when the business earns a decent return on that book value. Here ROE is 1.59% and ROCE is only 7.05%. That is not a wonderful franchise; it is a sub-scale asset barely earning its keep. Sales are down 70.21% and profits down 95.24%. The P/E of 72.12 is not a growth multiple; it is a distorted number because the E in the denominator has nearly disappeared. The Piotroski F-score of 3/9 reinforces weak financial health. There is no dividend to compensate me while waiting. I cannot calculate a moat from a collapsed revenue base. Specialty chemicals can be a good industry, but a good industry does not automatically make a good business. The only Graham-like attraction is that the price is 1.01 times book value, so I am not paying much above net asset value. But if the business is shrinking and profits are zero, book value can erode or become less recoverable. I need evidence of stabilization: two or three quarters of flat-to-growing sales, positive net profit, and transparency on promoter holding and debt. Without that, this remains a statistical bargain in search of a business. In Buffett's words, it is far better to buy a wonderful company at a fair price than a mediocre company at a bargain price. I will pass unless operations turn around convincingly.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer